With 1.33 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.25 million shares. The 52-week range on CPRX shows that it touched its highest point at $26.16 and its lowest point at $14.47 during that stretch. It currently has a 1-year price target of $34.00. Beta for the stock currently stands at 0.74.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CPRX was down-trending over the past week, with a drop of -3.42%, but this was up by 7.57% over a month. Three-month performance surged to 0.26% while six-month performance rose 7.17%. The stock gained 59.37% in the past year, while it has gained 12.41% so far this year. A look at the trailing 12-month EPS for CPRX yields 1.31 with Next year EPS estimates of 1.68. For the next quarter, that number is 0.36. This implies an EPS growth rate of 8.65% for this year and 18.27% for next year. EPS is expected to grow by 12.45% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 34.27%.
Float and Shares Shorts:
At present, 120.88 million CPRX shares are outstanding with a float of 111.11 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CPRX since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.22763 being high and $1.18591 being low. For CPRX, this leads to a yearly average estimate of $1.21571. Based on analyst estimates, the high estimate for the next quarter is $0.62 and the low estimate is $0.34. The average estimate for the next quarter is thus $0.49.
